Keywords: CCND1، cyclin D1; ADH1B, alcohol dehydrogenase 1B; AKR1B10, aldo-keto reductase 1B10; ALT, alanine aminotransferase; CCND1, cyclin D1; CLDN1, claudin 1; CYP7A1, cytochrome P450 7A1; DMSO, dimethyl sulfoxide; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HNF4α, hepatocyt
مقالات ISI CCND1، cyclin D1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CCND1، cyclin D1; AR, androgen receptor; ALH, atypical lobular hyperplasia; BC, breast cancer; BCS, breast-conserving surgery; CCND1, cyclin D1; CDH1, gene symbol for E-cadherin; CGH, comparative genomic hybridization; CTNNA1, gene symbol for α-catenin; CTNND1, gene symbol
Keywords: CCND1، cyclin D1; ANOVA, analysis of variance; ARG1, arginase-1; ATR, ataxia telangiectasia mutated–Rad3-related protein; BAK, BCL2-antagonist/killer; BAX, BCL2-associted X protein; CASP3, caspase 3; CCND1, cyclin D1; CDC2, cell division control 2; CDC7, cell division cycl
Evaluation of heterocyclic steroids and curcumin derivatives as anti-breast cancer agents: Studying the effect on apoptosis in MCF-7 breast cancer cells
Keywords: CCND1، cyclin D1; QRT-PCR, quantitative real time-polymerase chain reaction; CCND1, cyclin D1; IAP, inhibitor of apoptosis; TLC, thin layer chromatography; JCBN, joint commission on the biochemical nomenclature; SRB, sulforhodamine B; tr, retention time; ATCC, American Typ
Expression profiles of MiRNAs for intrinsic musculature of the forepaw and biceps in the rat model simulating irreversible muscular atrophy of obstetric brachial plexus palsy
Keywords: CCND1، cyclin D1; Acsl3, acyl-CoA synthetase long-chain family member 3; Bdnf, brain-derived neurotrophic factor; Ccnd1, cyclin D1; Erbb, erb-b2 receptor tyrosine kinase; FDR, false discovery rate; Fgf9, fibroblast growth factor 9; FGFBP1, fibroblast growth factor binding
5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis
Keywords: CCND1، cyclin D1; ALA, 5-aminolevulinic acid; ALA-SDT, 5-aminolevulinic acid-mediated sonodynamic therapy; BCL2, B-cell CLL/lymphoma 2; CCND1, cyclin D1; CDK6, cyclin-dependent kinase 6; DCF, dichlorofluorescein; DCFH-DA, 2′,7′-dichlorofluorescin diacetate; miRNAs, microRN
TRPV6 channel modulates proliferation of insulin secreting INS-1E beta cell line
Keywords: CCND1، cyclin D1; Ccnd1, cyclin D1; Ccnd2, cyclin D2; Cdk4, cyclin-dependent kinase 4; ERK1/2, extracellular-signal-regulated kinase 1 and 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Irs2, insulin receptor substrate 2; Ins, insulin; TRPV6, transient receptor potent
Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme
Keywords: CCND1، cyclin D1; BH, Benjamin and Hochberg; CAMs, cell adhesion molecules; CCND1, cyclin D1; CDK2, cyclin-dependent kinase 2; DEGs, differentially expressed genes; DLG4, disks large homologue 4; EGFR, epidermal growth factor receptor; FDR, false discovery rate; FGFR, fibr
A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome
Keywords: CCND1، cyclin D1; AKT, v-akt murine thymoma viral oncogene homolog 1; ALPS, autoimmune lymphoproliferative syndrome; AP-1, activator protein 1; CASP10, caspase-10; CCND1, cyclin D1; DN T cells, double negative T cells; ERK1/2, extracellular-signal regulated kinase 1/2; Fas
Wnt signaling pathway: Implications for therapy in lung cancer and bone metastasis
Keywords: CCND1، cyclin D1; APC, adenomatosis polyposis coli; CaMKII, calcium/calmodulin-dependent protein kinase II; CSC, cancer stem cell; CCND1, Cyclin D1; Cox-2, Cyclooxygenase 2; Dkk, dickkopf; Dvl, dishevelled; Fz, frizzled; GSK-3β, glycogen synthase kinase 3β; JNK, c-Jun N-te
Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909
Keywords: CCND1، cyclin D1; PBMCs, Peripheral blood mononuclear cells; CCND1, Cyclin D1; CYLD, Cylindromatosis; SP1, Specificity Protein 1; KLF4, Kruppel-like factor4; AATF, Apoptosis Antagonizing Transcription factor; BCL3, B-cell Lymphoma 3; NFkB, Nuclear factor kappa B; FCS, Feta
Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc
Keywords: CCND1، cyclin D1; RCC, renal cell carcinoma; let-7a, hsa-let-7a; CCK-8, cell counting kit-8; qRT-PCR, quantitative real-time PCR; PCNA, proliferating cell nuclear antigen; CCND1, cyclin D1; miRNAs, microRNAs; ATCC, American Type Culture Collection; GAPDH, glyceraldehyde-3-
The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population
Keywords: CCND1، cyclin D1; AHR, adjusted hazard ratio; BQ, betel quid; CCND1, cyclin D1; CI, confidence interval; HR, hazard ratio; OR, odds ratio; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphisms; SD, standard deviation; SNP, single nucleotide polymo
Comparative expression analysis in mature gonads, liver and brain of turbot (Scophthalmus maximus) by cDNA-AFLPS
Keywords: CCND1، cyclin D1; AFLP, amplified fragment length polymorphism; ATP, adenosine triphosphate; B2M, microglobulin b2; bet1l, blocked early in transport 1 homolog (S. cerevisiae)-like; bp, base pair(s); CCND1, Cyclin D1; cDNA, DNA complementary to RNA; cDNA-AFLP, cDNA-amplifi
Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case–control study
Keywords: CCND1، cyclin D1; HCC, hepatocellular carcinoma; CCND1, cyclin D1; OR, odds ratio; CI, confidence intervalHepatocellular carcinoma; Cyclin D1 G870A polymorphism; PCR–RFLP; Single nucleotide polymorphism; Susceptibility
MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal crypts
Keywords: CCND1، cyclin D1; Adcy6, adenylate cyclase type 6; BCL2, B-cell lymphoma 2; BrdU, 5-bromo-2-deoxyuridine; Ccnd1, cyclin D1; Ccnd2, cyclin D2; Ccnd3, cyclin D3; Ccne1, cyclin E1; Cdk4, cyclin-dependent kinase 4; Cdk6, cyclin-dependent kinase 6; HALO, hours after light onset
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
Keywords: CCND1، cyclin D1; miRNA, microRNA; 3′-UTR, 3′-untranslated region; mRNA, messenger RNA; CCND1, cyclin D1; CCND3, cyclin D3; CCNE2, cyclin E2; CDK4/6, cyclin-dependent kinase 4/6; MET, hepatocyte growth factor receptorMicroRNA; miR-34a; CCND1; CDK6; Cell cycle
Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer
Keywords: CCND1، cyclin D1; MDA, malondialdehyde; TEP, 1,1,3,3-tetraethoxypropane; GST, glutathione S-transferase; CCND1, cyclin D1; Nu.P1, nuclease P1; PNK, polynucleotide kinase; PEI, poly(ethyleneimine); TLC, thin-layer chromatography; RAL, relative adduct labeling; FR, frequency
Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients
Keywords: CCND1، cyclin D1; CCND1, cyclin D1; NSCLC, non-small cell lung cancer; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphismLung cancer; Cyclin D1; Gene polymorphism; Smoking; Chemotherapy; Predictive factor
Differentially expressed genes in the rat cochlear nucleus
Keywords: CCND1، cyclin D1; transcriptome; microarray; SAGE; auditory; molecularAgt, angiotensinogen; AVCN, anterior ventral cochlear nucleus; Calb2, calbindin 2; Ccnd1, cyclin D1; CD24, CD 24 antigen; DCN, dorsal cochlear nucleus; HPRT, hypoxanthine guanine phosphoribosyl transfera